Crow Point Partners’s Exact Sciences EXAS Stock Holding History

Crow Point Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$486K	Buy	+5,294	New	+$465K	0.76%	30
2019 Q2	–	Sell	-3,040	Closed	-$263K	–	124
2019 Q1	$263K	Sell	3,040 -4,060	-57%	-$346K	0.04%	91
2018 Q4	$434K	Sell	7,100 -2,033	-22%	-$140K	0.08%	63
2018 Q3	$721K	Sell	9,133 -526	-5%	-$34.3K	0.12%	62
2018 Q2	$584K	Buy	9,659 +7,249	+301%	+$390K	0.11%	66
2018 Q1	$97K	Sell	2,410 -244	-9%	-$11.9K	0.02%	134
2017 Q4	$145K	Buy	+2,654	New	+$142K	0.02%	146

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Crow Point Partners's EXAS Position: Q4 2019 in Review

Crow Point Partners opened a new position in Exact Sciences (EXAS) in Q4 2019: 5,294 shares worth $486K. The stake represents 0.76% of the portfolio and ranks #30 among its holdings. This is a return to the name: Crow Point Partners previously reported a position in EXAS as recently as Q1 2019.

Crow Point Partners first reported a position in EXAS in Q4 2017 and has held it in 7 quarters since. The position peaked at $721K in Q3 2018. 527 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

Crow Point Partners held 5,294 shares of Exact Sciences worth $486K as of Q4 2019.
Exact Sciences was a new Crow Point Partners position in Q4 2019.
Exact Sciences made up 0.76% of Crow Point Partners's portfolio in Q4 2019, its #30 holding.
Crow Point Partners first reported a position in Exact Sciences in Q4 2017 and has held it in 7 quarters since.
Crow Point Partners's Exact Sciences position peaked at $721K in Q3 2018.
527 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Crow Point Partners's 13F filing for Q4 2019, filed 14 Feb 2020.